de Novo Glioblastoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma (NCT02820584) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2016-09-01 |
Track de Novo Glioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.